Headquartered in Phoenix, Arizona, Axolotl Biologix is focused on researching to optimize the use of human biologicals and to develop biological-related products that will foster regeneration and healing for many conditions that affect patients. These conditions include orthopedic, wound care, pain management, ophthalmic, cardiovascular, cosmetic, and more. Axolotl is currently negotiating partnerships with leading universities and research hospitals to find ways to improve current technologies and procedures to improve patients’ quality of life.
Phillip Larson, President of Axolotl Biologix, is a founding member of this innovative biotechnology startup with a focus on improving patients’ quality of life through research, technology and clinical application of regenerative medicine. He started Axolotl Biologix in 2016 to help patients heal faster by expanding the body’s ability to regenerate cells.